RxDoctor Payments Data

Thomas Powell

Rheumatology · Orange, CANPI 1790742054

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Amgen at 24.4% of the total. Reporting peaked in 2019 at $3,455 and has fallen 98.2% since, to $64 in 2022.

$3,552in general payments, 2019–2025

Across 223 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$866
  • Johnson & Johnson$586
  • AbbVie$389
  • Bristol Myers Squibb$297
  • Novartis$265
  • Pfizer$225
  • plus $925 from 11 others

What the payments were for

  • Food & beverage$3,545100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,552 in reported general payments places this provider in the 55th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California →

Other rheumatology in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →